The "Why" Behind Enforcement Is The Key FDA Transparency Issue
This article was originally published in The Tan Sheet
Enforcement is the most critical area where FDA must be more transparent, said Natural Product Association executive Daniel Fabricant
You may also be interested in...
FDA has expanded its transparency initiative to cover an unanticipated area - explaining how the agency works to the industries it regulates
Supplement industry leaders want FDA's Transparency Task Force to shed light on the agency's decision-making process and explain controversial and ambiguous policies as well as improve communication
FDA's warning letter to General Mills concerning cardiovascular health claims linked to Cheerios reflects a newly empowered agency and foreshadows aggressive regulatory activity to come, experts say